Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
305.06
-5.21 (-1.68%)
At close: Nov 17, 2026, 4:00 PM EST
307.00
+1.94 (0.64%)
After-hours: Nov 17, 2026, 7:30 PM EST
PRAX Market Cap
PRAX has a market cap or net worth of $8.53 billion as of November 17, 2026. It is the 2,341st most valuable company in the world and the 825th biggest in the United States. Its market cap has increased by 82.91% in one year.
Market Cap
8.53B
Enterprise Value
7.24B
1-Year Change
82.91%
Global Rank
Country Rank
#825 United States
Category
ChartMarket Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.53B, an increase of 1,121.58%. That is a compound annual growth rate of 50.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 8.53B | 15.69% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 10.89B |
| Vaxcyte | 10.03B |
| Madrigal Pharmaceuticals | 9.93B |
| Spyre Therapeutics | 9.88B |
| Krystal Biotech | 9.05B |
| TG Therapeutics | 9.04B |
| Protagonist Therapeutics | 8.55B |
| Corcept Therapeutics | 7.98B |